GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study
GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study. // International Journal of Cardiology. – URL: https://www.sciencedirect.com/science/article/pii/S0167527326008508?dgcid=rss_sd_all
GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study. International Journal of Cardiology. https://www.sciencedirect.com/science/article/pii/S0167527326008508?dgcid=rss_sd_all
“GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study.” International Journal of Cardiology.
@article{article49682,
title = {GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study},
journal = {International Journal of Cardiology},
url = {https://www.sciencedirect.com/science/article/pii/S0167527326008508?dgcid=rss_sd_all}
}